News

Asieris Pharmaceuticals is invited to present at the China Bio Partnership Forum 2016

Scenes at the European Association of Urology (EAU) 2016 Congress

Interim results of China Phase II Clinical Trial of APL-1202 accepted for presentation

Asieris nominated as one of Jiangsu’s “Innovation and Entrepreneurship Top 60” SMEs

Asieris completed enrollment for its China Phase II Trial of APL-1202

Asieris won a Small to Medium-Size Technological Enterprise (SME) in Jiangsu

Dr. Kevin Pan was selected as a member of “113 Talent Program”

Dr. Yuh visited Nanjing iDatastat, the CRO for APL-1202’s China phase II trial

Asieris initiated TV interview for APL-1202 China phase 2 clinical trial

Asieris held an investigators’ meeting for APL-1202’s phase II clinical trial in China